Adam L Burrack

4PUBLICATIONS
29CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 26, 2026
T<sub>reg</sub> cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I-deficient metastatic pancreatic cancer.

|Mar 12, 2025
IL-15 Complex Enhances Agonistic Anti-CD40 + Anti-PDL1 by Correcting the T-bet to Tox Ratio in CD8+ T cells Infiltrating Pancreatic Ductal Adenocarcinoma.

Zoe C Schmiechen, Hezkiel A Nanda, Adam L Burrack

|Feb 25, 2022
Insufficiency of compound immune checkpoint blockade to overcome engineered T cell exhaustion in pancreatic cancer.

Ingunn M Stromnes, Ayaka Hulbert, Meagan R Rollins

|Feb 09, 2021
CD40 Agonist Overcomes T Cell Exhaustion Induced by Chronic Myeloid Cell IL-27 Production in a Pancreatic Cancer Preclinical Model.

Adam L Burrack, Meagan R Rollins, Ellen J Spartz

Pageof 1

Frequent Collaborators

4 joint publications

Ingunn M Stromnes

3 joint publications

Zoe C Schmiechen

2 joint publications

Meagan R Rollins

2 joint publications

Cara-Lin Lonetree